Mineralys Therapeutics Statistics

Total Valuation

MLYS has a market cap or net worth of $621.61 million. The enterprise value is $358.01 million.

Market Cap	621.61M
Enterprise Value	358.01M

Important Dates

The last earnings date was Monday, November 11, 2024, after market close.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	n/a

Share Statistics

MLYS has 49.77 million shares outstanding. The number of shares has increased by 67.83% in one year.

Current Share Class	49.77M
Shares Outstanding	49.77M
Shares Change (YoY)	+67.83%
Shares Change (QoQ)	+0.93%
Owned by Insiders (%)	2.56%
Owned by Institutions (%)	56.59%
Float	27.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.62
P/TBV Ratio	2.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.55

Current Ratio	8.55
Quick Ratio	8.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.19% and return on invested capital (ROIC) is -42.01%.

Return on Equity (ROE)	-61.19%
Return on Assets (ROA)	-38.55%
Return on Capital (ROIC)	-42.01%
Revenue Per Employee	n/a
Profits Per Employee	-$5.47M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.48% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+107.48%
50-Day Moving Average	13.05
200-Day Moving Average	12.86
Relative Strength Index (RSI)	46.29
Average Volume (20 Days)	262,736

Short Selling Information

The latest short interest is 1.39 million, so 2.79% of the outstanding shares have been sold short.

Short Interest	1.39M
Short Previous Month	1.61M
Short % of Shares Out	2.79%
Short % of Float	5.14%
Short Ratio (days to cover)	10.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-168.35M
Pretax Income	-90.80M
Net Income	-153.25M
EBITDA	n/a
EBIT	-168.35M
Earnings Per Share (EPS)	-$3.33

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	263.60M
Total Debt	n/a
Net Cash	263.60M
Net Cash Per Share	$5.30
Equity (Book Value)	236.93M
Book Value Per Share	4.76
Working Capital	236.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$128.45 million and capital expenditures -$96,000, giving a free cash flow of -$128.55 million.

Operating Cash Flow	-128.45M
Capital Expenditures	-96,000
Free Cash Flow	-128.55M
FCF Per Share	-$2.58

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-67.83%
Shareholder Yield	-67.83%
Earnings Yield	-24.65%
FCF Yield	-20.68%

Analyst Forecast

The average price target for MLYS is $30.00, which is 140.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	140.19%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	5.06%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1